Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benaglutide plus sitagliptin versus benaglutide alone in metformin-treated type 2 diabetes with inadequate glycemic control
ChiCTR1800017126Phase 4Not yet recruiting
- Sponsor
- Fuwai Hospital
- Start
- Jul 2018
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of beinaglutide and sitagliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Fuwai Hospital. Primary endpoints: HbA1c and blood glucose. Planned start Jul 2018; status: not yet recruiting.
02
Drugs
beinaglutidesitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR1800017126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017126.